End-payors defend state claims against Warner Chilcott in Loestrin 24 case
MLex Summary: End-payor plaintiffs have opposed Warner Chilcott’s motion to dismiss state claims accusing it of illegally delaying generic entry of Loestrin 24. They argue that Warner’s motion improperly relies on...To view the full article, register now.
Already a subscriber? Click here to view full article